Venus Remedies gets Argentina marketing approval for antibiotic Ceftriaxone to expand Latin America footprint

Approval in Argentina could accelerate access for serious infections

Venus Remedies says it has secured Argentina marketing approval for Ceftriaxone, a key antibiotic used to treat serious bacterial infections. The authorization is a major milestone in the company’s Latin America expansion, with Argentina highlighted as an important market for critical care therapies. The move strengthens Venus Remedies’ international presence and its focus on more accessible anti-infective treatments.